Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

ChromaCode, Inc.

start up
  • 08/06/2023
  • Unknown
  • Undisclosed Amount

ChromaCode is a molecular diagnostics company with a bioinformatics focus and pedigree from Illumina, Google[x], Luminex, and Caltech. We leverage patented mathematical methods and algorithmic enhancements to enrich signal processing from the most popular life science instrumentation. We are using this to extract new information on biochemistry reactions and substantially increase the performance capabilities of today’s gold-standard biochemical assays at a very low cost. Visit us at www.chromacode.com.


Related People

Mark McDonoughFounder

Mark McDonough United States - ND

"Strive for perfection, settle for excellence."
Dynamic, energetic Healthcare executive who enjoys leading from the front and increasing value to his companies. Have held various CEO, CBO, CCO, and Head of Sales roles. As as a public company CEO, led a wonderful team to a successful turnaround at CombiMatrix culminating in an exit with a sale of the company to Invitae. I enjoy building companies and commercial organizations from the ground up; exercise and working out; and spending time with my incredible family.

I bring expertise in:

• Extreme Ownership
• Team Leadership
• . Molecular Diagnostics (Reimbursement, FDA, and new product launch)
• Company Turnarounds
• Building teams (large and small)